Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma

Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma

Abstract Circulating tumor cells (CTCs) have been shown as a surrogate for cancer progression and prognostication. We aimed to determine an association between CTCs and survival of hepatocellular carcinoma (HCC) patients. Peripheral blood was obtained from 73 HCC patients to enumerate for epithelial...

Full description

Bibliographic Details
Main Authors: Thaninee Prasoppokakorn, Areeya Buntho, Praewphan Ingrungruanglert, Thodsawit Tiyarattanachai, Tassanan Jaihan, Kittipat Kulkraisri, Darlene Ariyaskul, Chonlada Phathong, Nipan Israsena, Rungsun Rerknimitr, Sombat Treeprasertsuk, Roongruedee Chaiteerakij
Format: Article
Language:English
Published: Nature Portfolio 2022-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-21888-9

Internet

https://doi.org/10.1038/s41598-022-21888-9

Similar Items